Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Sleep disturbance has been long-standing torments in most of patients with maintenance hemodialysis (HD). In this study, we attempted to explore whether long-term hemoperfusion (HP) could improve sleep disorder and increase overall survival rate in HD patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HD(hemodialysis) group | No Intervention | HD group as conventional control arm | |
| HD+HP(hemodialysis+hemoperfusion) group | Active Comparator | HD+HP as active interventional group.HP was performed 1-2 times/per 2 weeks, and each session lasted for two hours. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| hemoperfusion(HP) | Device | These patients were computer-matched into two groups, involving 100 patients with absolute HD vs. 100 cases with HD+HP.HP was performed 1-2 times/per 2 weeks, and each session lasted for two hours.Self-reported sleep disturbance was evaluated before and after observational time (two-year period), which lasted at least 7 hours based on the recommendations presented by National Institute of Health (NIH). Sleep efficiency (%) was calculated as the ratio of sleep duration to total time in bed, and was multiplied by 100. |
| Measure | Description | Time Frame |
|---|---|---|
| improvement of self-reported sleep disturbance | Analysis of the sleep disturbance by using Pittsburgh Sleep Quality Index (PSQI) questionnaire | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| survival | increase overall survival rate | 2 years |
Not provided
Inclusion Criteria:
duration of maintenance HD should be equal or more than 3 months,
patient's age should be equal or more than 18 years
Exclusion Criteria:
- i) he/she diagnosed with malignant tumors, an active rheumatism, infectious diseases, or a severe heart failure ii) he/she would disagree with the study
he/she has received a short-term poor prognosis
he/she would be more than 80 years old
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006464 | Hemoperfusion |
| ID | Term |
|---|---|
| D017582 | Renal Replacement Therapy |
| D013812 | Therapeutics |
| D016060 | Sorption Detoxification |
| D005112 | Extracorporeal Circulation |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| D013514 | Surgical Procedures, Operative |